Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 36, Issue 3, 2007, Pages 333-342

  Blumen, Steven R ^b   Cheng, Kai ^b   Ramos Nino, Maria E ^b   Taatjes, Douglas J ^b   Weiss, Daniel J ^b   Landry, Christopher C ^b   Mossman, Brooke T ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Lung cancer; Mesothelioma; Nanoparticles; Particles; Uptake

Indexed keywords

ACID PREPARED MESOPOROUS SPHERE; AMINE; CD45 ANTIGEN; DRUG VEHICLE; GLYCOL; LIPID; NANOPARTICLE; SILICON DIOXIDE; TETRAETHYLENE GLYCOL; THIOL GROUP; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CAVEOLA; CHEMICAL MODIFICATION; COATED VESICLE; CONTROLLED STUDY; CYTOTOXICITY; DIAPHRAGM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG FIBROSIS; LUNG LAVAGE; LUNG PARENCHYMA; LYSOSOME; MALIGNANT MESOTHELIOMA; MEMBRANE FUSION; MOUSE; NONHUMAN; SPLEEN;

ADMINISTRATION, INTRANASAL; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELL DEATH; EPITHELIAL CELLS; HUMANS; HYDROCHLORIC ACID; L-LACTATE DEHYDROGENASE; LUNG; MESOTHELIOMA; MICE; MICROSPHERES; PLASMIDS; PLEURAL NEOPLASMS; POLYETHYLENE GLYCOLS; POROSITY; TIME FACTORS;

MURINAE; MUS;

EID: 33847670973     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2006-0319OC     Document Type: Article

References (37)

1. Borm PJ, Kreyling W. Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J Nanosci Nanotechnol 2004;4:521-531.
2. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nano-level. Science 2006;311:622-627.
3. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113:823-839.
4. United States Environmental Protection Agency. 2006. http://www.epa. gov/oar/particlepollution/fs20051220pm.html. Fact Sheet: Proposal to Revise the National Ambient Air Quality Standards for Particulate Matter.
5. Gallis KW, Araujo JT, Duff KJ, Moore JG, Landry CC. The use of mesoporous silica in chromatography. Adv Mater 1999;11:1452-1455.
6. Gallis KW, Landry CC. 2002. Mesoporous silica and method of making same. US Patent 6,334,988. USA.
7. Nassivera T, Eklund AG, Landry CC. Size-exclusion chromatography of low-molecular-mass polymers using mesoporous silica. J Chromatogr A 2002;973:97-101.
8. Guthrie GD, Mossman BT, editors. Health effects of mineral dusts, reviews in mineralogy. Washington, DC: Mineralogic Society of America; 1993.
9. Solberg SM, Landry CC. Adsorption of DNA into mesoporous silica. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2006;110:15261-15268.
10. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 2006;103:6315-6320.
11. Maruyama K. PEG-immunoliposome. Biosci Rep 2002;22:251-266.
12. Olivier JC. Drug transport to brain with targeted nanoparticles. NeuroRx 2005;2:108-119.
13. Olivier JC, Huertas R, Lee HJ, Calon F, Pardridge WM. Synthesis of pegylated immunonanoparticles. Pharm Res 2002;19:1137-1143.
14. Martin-Herranz A, Ahmad A, Evans HM, Ewert K, Schulze U, Safinya CR. Surface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimes. Biophys J 2004;86:1160-1168.
15. Huang M, Wu W, Qian J, Wan DJ, Wei XL, Zhu JH. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles. Acta Pharmacol Sin 2005;26:1512-1518.
16. Sadzuka Y, Sugiyama I, Tsuruda T, Sonobe T. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin. Int J Pharm 2006;312:83-89.
17. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, Borkowski S, Hilger CS, Cook G, Warren S, et al. Tumor targeting by an aptarner. J Nucl Med 2006;47:668-678.
18. Berna M, Dalzoppo D, Pasut G, Manunta M, Izzo L, Jones AT, Duncan R, Veronese FM. Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: synthesis, characterization and cellular uptake. Biomacromolecules 2006;7:146-153.
19. Matsumura Y, Gotoh M, Muro K, Yamada Y, Shirao K, Shimada Y, Okuwa M, Matsumoto S, Miyata Y, Ohkura H, et al. Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. Ann Oncol 2004;15:517-525.
20. Greenwald RB, Yang K, Zhao H, Conover CD, Lee S, Filpula D. Controlled release of proteins from their poly(ethylene glycol) conjugates: drug delivery systems employing 1,6-elimination. Bioconjug Chem 2003;14:395-403.
21. Greenwald RB, Choe YH, McGuire J, Conover CD. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev 2003;55:217-250.
22. Greenwald RB, Conover CD, Choe YH. Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review. Crit Rev Ther Drug Carrier Syst 2000;17:101-161.
23. Malkinson AM, Dwyer-Nield LD, Rice PL, Dinsdale D. Mouse lung epithelial cell lines-tools for the study of differentiation and the neoplastic phenotype. Toxicology 1997;123:53-100.
24. Carpino LA. 1-Hydroxy-7-azabenzotriazole: an efficient peptide coupling additive. J Am Chem Soc 1993;115:4397-4398.
25. Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994;127:1217-1232.
26. Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993;123:1107-1117.
27. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998;141:905-915.
28. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004;377:159-169.
29. Tsakiridis T, Vranic M, Klip A. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem 1994;269:29934-29942.
30. Ramos-Nino ME, Vianale G, Sabo-Attwood T, Mutti L, Porta C, Heintz N, Mossman BT. Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase. Mol Cancer Ther 2005;4:835-842.
31. Altomare DA, You H, Xiao GH, Ramos-Nino ME, Skele KL, De Rienzo A, Jhanwar SC, Mossman BT, Kane AB, Testa JR. Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene 2005;24:6080-6089.
32. Mossman BT, Kessler JB, Ley BW, Craighead JE. Interaction of crocidolite asbestos with hamster respiratory mucosa in organ culture. Lab Invest 1977;36:131-139.
33. Persson HL. Iron-dependent lysosomal destabilization initiates silica-induced apoptosis in murine macrophages. Toxicol Lett 2005;159:124-133.
34. Wiewrodt R, Thomas AP, Cipelletti L, Christofidou-Solomidou M, Weitz DA, Feinstein SI, Schaffer D, Albelda SM, Koval M, Muzykantov VR. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 2002;99:912-922.
35. Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm 2002;244:105-115.
36. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997;14:1568-1573.
37. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005;113:1555-1560.